NCT00280917Phase 2Completed

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Study sponsor: Can-Fite BioPharma

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2007-04Actual
Enrollment · participants254Actual
Source updated2023-09-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.